e. >> reporter: the review combines 14 studies involving more than 8,000 patients. while a 72% increased risk sounds alarming, the companion editorial titles, is it a heartbreaker? notes that cardiovascular problems including chest pain, heart attack and stroke are still rare. occurring in only about 1% of patients taking chantix. the drugmaker pfizer questions the way the analysis was conducted.